Practice-Changing Studies from American College of Gastroenterology 2019
Dr KK Aggarwal
President CMAAO and HCFI
1. Oral Budesonide suspension 2 mg for 12 weeks shows Striking Efficacy for Eosinophilic Esophagitis
2. Avoidant/restrictive food intake disorder (ARFID) is increasingly being emphasized in adult gastroenterology. This is a diagnosis that's established by restriction or avoidance of food intake that is associated with weight loss, nutritional deficiencies, dependence on tube feedings or oral supplements, or significant psychosocial impairment.
3. Vedolizumab for Ulcerative Colitis: Shift from IOV to SC now. It is a monoclonal antibody targeting the alpha-4 beta-7 integrin.
4. Obeticholic Acid, a selective farnesoid X receptor agonist, which regulates bile acid homeostasis is effective in NASH
5. There is no apparent Increased Risk for Metachronous Lesions in Young Adults With Adenomas
6. Hyperbaric Oxygen is a new indication for refractory Pouchitis
Dr KK Aggarwal
President CMAAO and HCFI
1. Oral Budesonide suspension 2 mg for 12 weeks shows Striking Efficacy for Eosinophilic Esophagitis
2. Avoidant/restrictive food intake disorder (ARFID) is increasingly being emphasized in adult gastroenterology. This is a diagnosis that's established by restriction or avoidance of food intake that is associated with weight loss, nutritional deficiencies, dependence on tube feedings or oral supplements, or significant psychosocial impairment.
3. Vedolizumab for Ulcerative Colitis: Shift from IOV to SC now. It is a monoclonal antibody targeting the alpha-4 beta-7 integrin.
4. Obeticholic Acid, a selective farnesoid X receptor agonist, which regulates bile acid homeostasis is effective in NASH
5. There is no apparent Increased Risk for Metachronous Lesions in Young Adults With Adenomas
6. Hyperbaric Oxygen is a new indication for refractory Pouchitis
No comments:
Post a Comment